TLR signaling and DNA repair: Are they associated?

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 296-302

  Harberts, Erin ^a   Gaspari, Anthony A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 4; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR AP 1; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOCRINE EFFECT; BINDING SITE; CD4+ T LYMPHOCYTE; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; EXCISION REPAIR; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84872595868     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.288     Document Type: Review

References (63)

1. Alexandrescu DT, Ichim TE, Riordan NH et al. (2010) Immunotherapy for melanoma: current status and perspectives. J Immunother 33:570-90
2. Aziz K, Nowsheen S, Pantelias G et al. (2012) Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy. Pharmacol Ther 133:334-50
3. Azzam EI, Jay-Gerin JP, Pain D (2011) Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett; e-pub ahead of print 17 December 2011
4. Barton GM, Kagan JC (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 9:535-42
5. Bernard JJ, Cowing-Zitron C, Nakatsuji T et al. (2012) Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat Med; e-pub ahead of print 8 July 2012
6. Born AL, Born W (1987) Replicative and repair DNA synthesis after solar damage. Acta Derm Venereol Suppl 134:40-2
7. Bourquin C, Hotz C, Noerenberg D et al. (2011) Systemic cancer therapy with a small molecule agonist of Toll-like receptor 7 can be improved by circumventing TLR tolerance. Cancer Res 71:5123-33
8. Celhar T, Magalhaes R, Fairhurst AM (2012) TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res 53:58-77
9. Dietrich N, Lienenklaus S, Weiss S et al. (2010) Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PloS One 5:e10250
10. Dizdaroglu M (2012) Oxidatively induced DNA damage: mechanisms, repair and disease. Cancer Lett; e-pub ahead of print 28 January 2012
11. Dumitru CD, Antonysamy MA, Tomai MA et al. (2010) Potentiation of the anti-tumor effects of imidazoquinoline immune response modifiers by cyclophosphamide. Cancer Biol Ther 10:155-65
12. Edwards L, Ferenczy A, Eron L et al. (1998) Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human Papilloma Virus. Arch Dermatol 134:25-30
13. Evans MD, Cooke MS (2004) Factors contributing to the outcome of oxidative damage to nucleic acids. BioEssays 26:533-42
14. Fishelevich R, Zhao Y, Tuchinda P et al. (2011) Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells. J Immunol 187:1664-73
15. Ganguly D, Chamilos G, Lande R et al. (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206:1983-94
16. Gaspari AA, Fleisher TA, Kraemer KH (1993) Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 92:1135-42
17. Gill R, Tsung A, Billiar T (2010) Linking oxidative stress to inflammation: Tolllike receptors. Free Radic Biol Med 48:1121-32
18. Goh FG, Midwood KS (2012) Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 51:7-23
19. Hanke CW, Beer KR, Stockfleth E et al. (2010) Imiquimod 2.5 and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol 62:573-81
20. Huang H, Evankovich J, Yan W et al. (2011) Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 54:999-1008
21. Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-50
22. Klaschik S, Tross D, Shirota H et al. (2010) Short-and long-term changes in gene expression mediated by the activation of TLR9. Mol Immunol 47: 1317-24
23. Krysko DV, Agostinis P, Krysko O et al. (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32:157-64
24. Kuipers MT, van der Poll T, Schultz MJ et al. (2011) Bench-to-bedside review: damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care 15:235
25. Lande R, Gregorio J, Facchinetti V et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-9
26. Larange A, Antonios D, Pallardy M et al. (2009) TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol 85:673-83
27. Lee KH, Liu YJ, Biswas A et al. (2011) A novel aminosaccharide compound blocks immune responses by Toll-like receptors and nucleotide-binding domain, leucine-rich repeat proteins. J Biol Chem 286:5727-35
28. Lewis W, Simanyi E, Li H et al. (2011) Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4. Arch Biochem Biophys 508:171-7
29. Loegering DJ, Lennartz MR (2011) Protein kinase C and toll-like receptor signaling. Enzyme Res 2011:537821
30. Majewski S, Jantschitsch C, Maeda A et al. (2010) IL-23 antagonizes UVR-induced immunosuppression through two mechanisms: reduction of UVR-induced DNA damage and inhibition of UVR-induced regulatory T cells. J Invest Dermatol 130:554-62
31. Marichal T, Ohata K, Bedoret D et al. (2011) DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 17:996-1002
32. Maroso M, Balosso S, Ravizza T et al. (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16:413-9
33. McGettrick AF, O'Neill LA (2010) Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol 22:20-7
34. Menendez D, Shatz M, Azzam K et al. (2011) The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 7:e1001360
35. Miller YI, Choi SH, Wiesner P et al. (2011) Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 108:235-48
36. Mittal D, Saccheri F, Venereau E et al. (2010) TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J 29:2242-52
37. Muthusamy V, Piva TJ (2010) The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways. Arch Dermatol Res 302:5-17
38. Nace G, Evankovich J, Eid R et al. (2012) Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity. J Innate Immun 4:6-15
39. Natarajan AT, van Zeeland AA, Obe G (1988) Some studies on the DNA-repair-eliciting and genotoxic activity of cell-free extracts of Lactoba-cillus bifidus. Mutat Res 206:47-54
40. Norval M, Halliday GM (2011) The consequences of UV-induced immuno-suppression for human health. Photochem Photobiol 87:965-77
41. Oster-Schmidt C (2004) Two cases of squamous cell carcinoma treated with topical imiquimod 5%. J Eur Acad Dermatol Venereol 18:93-5
42. Park SJ, Youn HS (2010) Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin. Phytochemistry 71:1736-40
43. Piccinini AM, Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm; e-pub 13 July 2010, pii: 672395
44. Prince LR, Whyte MK, Sabroe I et al. (2011) The role of TLRs in neutrophil activation. Curr Opin Pharmacol 11:397-403
45. Rastogi RP, Richa, Kumar A et al. (2010) Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010: 592980
46. Rubin RL, Tang FL, Chan EK et al. (1986) IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. J Immunol 137:2528-34
47. Schwarz T, Schwarz A (2009) DNA repair and cytokine responses. J Investig Dermatol Symp Proc 14:63-6
48. Shibata T, Motoi Y, Tanimura N et al. (2011) Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes. Int Immunol 23:503-10
49. Sommariva M, De Cecco L, De Cesare M et al. (2011) TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res 71:6382-90
50. Sun S, Rao NL, Venable J et al. (2007) TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allergy Drug Targets 6:223-35
51. Swanson N, Abramovits W, Berman B et al. (2010) Imiquimod 2.5 and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol 62:582-90
52. Tang D, Kang R, Zeh 3rd HJ et al. (2011) High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 14:1315-35
53. Thatcher TH, Luzina I, Fishelevich R et al. (2006) Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance. J Invest Dermatol 126:821-31
54. Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7:179-90
55. Tsukamoto Y, Nagai Y, Kariyone A et al. (2009) Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production. Mol Immunol 46:1278-88
56. Ubol S, Halstead SB (2010) How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 17:1829-35
57. Vink AA, Strickland FM, Bucana C et al. (1996) Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med 183:1491-500
58. Waltz P, Carchman EH, Young AC et al. (2011) Lipopolysaccaride induces autophagic signaling in macrophages via a TLR4, heme oxygenase-1 dependent pathway. Autophagy 7:315-20
59. Wheeler DS, Chase MA, Senft AP et al. (2009) Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir Res 10:31
60. Xiao W, Singh KK, Chen B et al. (1993) A common element involved in transcriptional regulation of two DNA alkylation repair genes (MAG and MGT1) of Saccharomyces cerevisiae. Mol Cell Biol 13:7213-21
61. Yu M, Wang H, Ding A et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174-9
62. Zheng L, Asprodites N, Keene AH et al. (2008) TLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elements. Blood 111:2704-13
63. Zhong X, Thornton K, Reed E (2000) Computer based analyses of the 5'-flanking regions of selected genes involved in the nucleotide excision repair complex. Int J Oncol 17:375-80